Basket | Login | Register

 
 
 
 

The EPAD project congratulates its Trial Delivery Centre of the Month

Thursday 08 February 2018

The European Prevention of Alzheimer’s Dementia (EPAD) consortium is delighted that the team of CITA Foundation (pictured) screened 16 research participants in January 2018 for their inclusion in the EPAD Longitudinal Cohort Study, making it the most successful trial delivery centre that month.

The CITA Foundation (San Sebastian, Spain) opened as a new EPAD Trial Delivery Center in June 2017. It is a private, non-profit foundation whose vision is to be an international benchmark institution in research on Alzheimer’s disease and to contribute to the wellbeing of society through the transfer of knowledge generated and the creation of economic value. For more information visit http://www.cita-alzheimer.org/

The CITA Foundation is an active partner of EPAD which currently has 11 participating sites. Several sites have been opened in England, France, Netherlands, Scotland, Spain, Sweden and the latest site to enroll research participants is Oxford, UK. 453 research participants have already been screened of which 417 are currently enrolled. EPAD is poised to open further sites in Europe in the coming weeks.

Pictured: from the left:

  • Standing: Montse Clerigue. Jon Saldias, Ane Iriondo, Maria Arribas, Maite Garcia ,Pablo Martinez Láge, Ainara Estanga , Amaya Garcia Eizaga, Fernando Boada
  • Seated: Mikel Tainta, Maite Murillo, Zigor Diaz, Mirian Ecay

The EPAD project has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115736, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution.

Options